Atlas Trials

The Tetrad BMI, Leptin, Leptin/Adiponectin (L/A) Ratio and CA-15-3 is a Reliable Biomarker of Breast Cancer

Clinical trial NCT01643148 · COMPLETED

Trial details

NCT number
NCT01643148
Sponsor
Materno-Perinatal Hospital of the State of Mexico
Status
COMPLETED
Study type
OBSERVATIONAL
Female Breast Carcinoma
Start date
2011-01-01
Primary completion
2011-10-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.